Sionna Therapeutics Ownership | Who Owns Sionna Therapeutics?

Sionna Therapeutics Ownership Summary

Sionna Therapeutics is owned by 156.01% institutional investors.

SION Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sionna Therapeutics	156.01%	-	-56.01%
Sector	Healthcare Stocks	79.84%	9.81%	10.35%
Industry	Biotech Stocks	63.50%	9.87%	26.63%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	47	-	41,491,947	-	156	-	47	-	-	-

SION Ownership FAQ

Who Owns Sionna Therapeutics?

Sionna Therapeutics shareholders are primarily institutional investors at 156.01%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Sionna Therapeutics's industry, Biotech Stocks , is 63.50%, which Sionna Therapeutics exceeds.

Does Blackrock own Sionna Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Sionna Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools